President Donald Trump has nominated Dr. Casey Means, a physician and health tech entrepreneur, as the next U.S. Surgeon General. The announcement, made Wednesday, highlights Means' alignment with Health Secretary Robert F. Kennedy Jr.’s "Make America Healthy Again" initiative.
Dr. Means, 37, co-founded the health technology company Levels, which uses data from continuous glucose monitors to help users understand how their food choices affect metabolic health. She is a strong advocate for using personalized data to drive healthier lifestyles and is widely seen as a rising voice in the preventive health and biohacking movement.
Her brother, Calley Means, was recently appointed as a White House adviser, focusing on food policy reform and addressing corporate influence on national health trends. Together, the Means siblings have been vocal supporters of reshaping American health through nutrition-focused and tech-driven approaches.
Dr. Means will replace Trump’s previous nominee, Dr. Janette Nesheiwat, who the president announced will now serve in a different senior role within the Department of Health and Human Services alongside Secretary Kennedy.
As Surgeon General, Dr. Means would become the nation’s leading spokesperson on public health, responsible for delivering science-based guidance on disease prevention, wellness, and reducing chronic illness. Her nomination is expected to energize health reform advocates who support lifestyle medicine and digital health innovation.
Trump’s pick signals a continued shift toward preventive care and a broader embrace of alternative health strategies that prioritize nutrition, metabolic awareness, and data-driven wellness tools. The nomination must still be confirmed by the Senate.


Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Ghana Says Western Support Growing for Slave Trade Reparations
France Defends Netanyahu Airspace Clearance Despite ICC Warrant
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
Kremlin Says No Decision Yet on Putin-Trump December Summit
Yemen Violence Displaces 130,000 as Civilian Toll Rises
North Korea Warns South Korea Over US-Led Defense Role
Mexico-US Trade Talks Delayed to October as Tariff Negotiations Continue
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
France Keeps Top Health Alert as Officials Brace for Another Heatwave
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 



